Thursday, September 1, 2016

UPDATE 1-Weak Mylan board fosters EpiPen 'debacle' -New York comptroller

Sept 1 (Reuters) - New York City's comptroller on Thursday

criticized what he said are "exorbitant" price increases for

Mylan NV's allergy auto-injector EpiPen and said weak

board oversight of...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)